| Business Wire : OXiGENE's Lead Compound CA4P Enhances the Anti-Tumor Activity of Avastin in Pre-clinical Studies. | Digitalby Business Wire (Publisher)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Business Wire | | Page Count: | 3 Pages | | Sales Rank: | 7,453,609th |
|
|